Search

The ecological role of honeybees in the world and their value for sustainable agriculture and food industry are more important than ever. For this reason, we study the apiflora in the eastern Mediterranean region of Turkiye in the context of planning bee forests aimed at biodiversity conservation. The results show that honeybee forests are quite rich in both endemism and apifloristic diversity. A total of 511 plant taxa belonging to 264 genera and 59 families were identified, of which 335 (65%) taxa were evaluated as nectar (N) and/or pollen (P) bearing honey plants (45 N, 54 P, and 236 N&P). In terms of apiflora, the richest families are Fabaceae (n=76, 3 N, 73 N&P), Lamiaceae (n=57, 19 N, 38 N&P) and Asteraceae (n=44, 1 N, 10 P, 33 N&P). Nectariferous plants were more common at higher elevations, while polleniferous plants were more common at lower elevations. According to the Shannon-Wiener diversity index, the highest diversity values were found in honeybee forests at higher elevations and the lowest diversity values at lower elevations. Sorensen analysis also showed that floristic similarities among honeybee forests ranged from 1% to 42%. Cluster analysis supported these differences by dividing the forests into two separate groups.

Single-site Ir(CO)2 complexes bonded to high-surface-area metal oxide supports, SiO2, TiO2, Fe2O3, CeO2, MgO, and La2O3, were synthesized by chemisorption of Ir(CO)2(acac) (acac = acetylacetonate) followed by coating with each of the following ionic liquids (ILs): 1-n-butyl-3-methylimidazolium tetrafluoroborate, [BMIM][BF4], 1-n-butyl-3-methylimidazolium acetate, [BMIM][Ac], and 1-(3-cyanopropyl)-3-methylimidazolium dicyanamide, [CPMIM][DCA]. Extended X-ray absorption fine structure spectroscopy showed that site-isolated iridium was bonded to oxygen atoms of the support. Electron densities on the iridium enveloped by each IL sheath/support combination were characterized by carbonyl infrared spectroscopy of the iridium gem-dicarbonyls and by X-ray absorption near-edge structure data. The electron-donor/acceptor tendencies of both the support and IL determine the activity and selectivity of the catalysts for the hydrogenation of 1,3-butadiene, with electron-rich iridium being selective for partial hydrogenation. The results resolve the effects of the IL and support as ligands; for example, the effect of the IL becomes dominant when the support has a weak electron-donor character. The combined effects of supports and ILs as ligands offer broad opportunities for tuning catalytic properties of supported metal catalysts.

Copyright of Turkish Journal of Geographical Sciences / Coğrafi Bilimler Dergisi is the property of Cografi Bilimler Dergisi and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective Given the importance AI in genomics and its potential impact on human health, the American Medical Informatics Association—Genomics and Translational Biomedical Informatics (GenTBI) Workgroup developed this assessment of factors that can further enable the clinical application of AI in this space. Process A list of relevant factors was developed through GenTBI workgroup discussions in multiple in-person and online meetings, along with review of pertinent publications. This list was then summarized and reviewed to achieve consensus among the group members. Conclusions Substantial informatics research and development are needed to fully realize the clinical potential of such technologies. The development of larger datasets is crucial to emulating the success AI is achieving in other domains. It is important that AI methods do not exacerbate existing socio-economic, racial, and ethnic disparities. Genomic data standards are critical to effectively scale such technologies across institutions. With so much uncertainty, complexity and novelty in genomics and medicine, and with an evolving regulatory environment, the current focus should be on using these technologies in an interface with clinicians that emphasizes the value each brings to clinical decision-making. [ABSTRACT FROM AUTHOR]